A Randomized Phase 2 Trial Comparing Carfilzomib-Dexamethasone Vs Observation As Maintenance after Induction with Carfilzomib-Cyclophosphamide-Dexamethasone in Salvage ASCT in Multiple Myeloma: A Trial By the Nordic Myeloma Study Group
Gregersen, Henrik, Peceliunas, Valdas, Remes, Kari, Schjesvold, Fredrik H., Abildgaard, Niels, Nahi, Hareth, Andersen, Niels Frost, Vangsted, Annette Juul, Klausen, Tobias Wirenfeldt, Helleberg, Carsten, Carlson, Kristina, Frølund, Ulf Christian, Axelsson, Per, Stromberg, Olga, Blimark, Cecilie Hveding, Linder, Olle, Tsykunova, Galina, Waage, Anders, Hansson, Markus, Gulbrandsen, Nina
Published in BLOOD (13.11.2019)
Published in BLOOD (13.11.2019)
Get full text
Journal Article
Conference Proceeding
A Randomized Placebo-Controlled Phase II Study of Clarithromycin or Placebo Combined with VCD Induction Therapy Prior to High-Dose Melphalan with Stem Cell Support in Patients with Newly Diagnosed Multiple Myeloma
Gregersen, Henrik, Abildgaard, Niels, Hieu Do, Trung, Kristensen, Ida Bruun, Frølund, Ulf Christian, Andersen, Niels Frost, Nielsen, Lene Kongsgaard, Andersen, Christen Lykkegaard, Klausen, Tobias Wirenfeldt, Vangsted, Annette Juul
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article